Research

rs1049793 — AOC1 (DAO) His645Asp

DAO structural variant near the catalytic domain affecting histamine degradation

Strong Risk Factor

Details

Gene
AOC1 (DAO)
Chromosome
7
Risk allele
G
Protein change
p.His645Asp
Consequence
Missense
Inheritance
Codominant
Clinical
Risk Factor
Evidence
Strong
Chip coverage
v3 v4 v5

Population Frequency

CC
50%
CG
40%
GG
10%

Ancestry Frequencies

east_asian
54%
south_asian
49%
african
48%
latino
40%
european
30%

DAO His645Asp - The Third Piece of the DAO Puzzle

The His645Asp 11 Histidine to aspartic acid at position 645 variant (rs1049793) is the third major functional variant in the AOC1 gene encoding diamine oxidase. This missense mutation replaces histidine with aspartic acid at position 645, which sits near the enzyme's catalytic domain.

The Mechanism

Position 645 is in a region of the DAO protein that contributes to substrate binding and catalytic turnover. The aspartic acid substitution 22 Histidine is positively charged at physiological pH while aspartic acid is negatively charged, dramatically changing local electrostatics (G allele) alters the local charge distribution, potentially affecting how efficiently the enzyme captures and degrades histamine molecules. Like the other DAO structural variants, this change reduces the enzyme's overall effectiveness. Ayuso et al.33 Ayuso et al.
Ayuso P et al. Genetic variability of human diamine oxidase. Pharmacogenet Genomics, 2007
showed that heterozygous carriers had 34% reduced DAO activity and homozygous carriers had 49% reduced activity compared to non-carriers.

Combined DAO Status

The three major AOC1 variants (rs2052129, rs10156191, and rs1049793) together determine your overall DAO capacity. Research has demonstrated that these variants are partially independent - you can carry risk alleles at one position but not others. This means your total DAO function is best assessed by looking at all three variants together, rather than any single one in isolation.

Population Variation

This variant shows substantial population differences. The G allele frequency is approximately 30% in Europeans but reaches 49-54% in East Asian, South Asian, and African populations. This means reduced DAO activity at this position is more common in non-European populations.

Practical Guidance

The dietary strategies for managing reduced DAO function are consistent regardless of which specific variant is responsible: minimize high-histamine foods, prioritize freshness, and consider DAO supplementation with meals when consuming foods that are known histamine triggers. Importantly, histamine intolerance symptoms can wax and wane depending on your total histamine load 44 Your histamine load is the sum of all histamine from diet, gut bacteria, allergic reactions, and internal production at any given time from food, environment, stress, and hormonal fluctuations.

Nutrient Interactions

histamine altered_metabolism
copper increased_need

Genotype Interpretations

What each possible genotype means for this variant:

CC “Normal DAO Activity” Normal

Normal DAO at this position

Normal DAO enzyme at this structural position. About 50% of Europeans have this genotype.

CG “Mildly Reduced DAO” Intermediate Caution

One DAO structural variant

You carry one variant that may reduce DAO activity by approximately 34%. About 40% of Europeans share this genotype.

GG “Significantly Reduced DAO” Reduced Warning

Reduced DAO activity at this position

Two variants reducing DAO activity at this position by approximately 49%. About 10% of Europeans have this genotype, though it is more common in East Asian and African populations.

Key References

PMID: 17700358

Ayuso et al. showed His645Asp carriers had 34% reduced DAO activity (heterozygotes) and 49% reduced (homozygotes)

PMID: 21488903

Maintz et al. confirmed association of rs1049793 with reduced serum DAO activity in German cohort

PMID: 17490952

Maintz & Novak review of histamine intolerance and DAO deficiency mechanisms

PMID: 37359379

Duelo et al. cumulative effect of AOC1 gene variants on clinical symptoms in fibromyalgia